©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessPrenatal akinesia / hypokinesia

Summary

Short information

Comprehensive differential diagnostic panel for Prenatal akinesia / hypokinesia comprising 14 and altogether 68 curated genes according to the clinical signs

ID
PP3647
Number of genes
32 Accredited laboratory test
Examined sequence length
27,4 kb (Core-/Core-canditate-Genes)
100,7 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • Amniotic fluid (after amnocentesis)
  • Chorionic villus
  • Umbilical cord blood
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GHeredity
ASCC11074AR
BICD22568AD
CHRNA11374AD, AR
CHRND1554AD, AR
CHRNG1554AR
CNTN13057AR
DOK71515AR
ERCC1972AR
ERCC22283AR
ERCC64482AR
GBE12109AR
MUSK2610AR
MYOD1963AR
RAPSN1239n.k.
ECEL12328AR
ERCC32349AR
GLE12097AR
IRF61404AD
LGI41614AR
MAGEL23750AD
MYBPC13516AD, AR
MYH35823AD
MYH85814AD
NUP882291AR
PIEZO28259AD, AR
RIPK42355AD, AR
SYNE126250AD, AR
TNNI2549AD
TPM2855AD
VIPAS391482AR
VPS33B1854AR
ZC4H2675XLR

Informations about the disease

Clinical Comment

Multiple joint contractures, facial anomalies, pulmonary hypoplasia. Common feature is decreased foetal activity

 

Synonyms
  • Alias: Fetal akinesia deformation sequence
  • Alias: Prenatal akiesia/hypokinesia
  • Allelic: Barrett esophagus/esophageal adenocarcinoma (ASCC1)
  • Allelic: CAP myopathy 2 (TPM2)
  • Allelic: CHAND syndrome (RIPK4)
  • Allelic: Cardiomyopathy, dilated, 1G (TTN)
  • Allelic: Cardiomyopathy, familial hypertrophic, 9 (TTN)
  • Allelic: Cockayne syndrome, type B (ERCC6)
  • Allelic: De Sanctis-Cacchione syndrome (ERCC6)
  • Allelic: Emery-Dreifuss muscular dystrophy 4, AD (SYNE1)
  • Allelic: Erythroleukemia, familial, susceptibility to (ERBB3)
  • Allelic: Heart-hand syndrome, Slovenian type (LMNA)
  • Allelic: Hutchinson-Gilford progeria (LMNA)
  • Allelic: Intellectual developmental disorder, AD 56 (CLTC)
  • Allelic: Lipodystrophy, familial partial, type 2 (LMNA)
  • Allelic: Malignant hyperthermia susceptibility 1 (RYR1)
  • Allelic: Malignant hyperthermia susceptibility 5 (CACNA1S)
  • Allelic: Malouf syndrome (LMNA)
  • Allelic: Mandibuloacral dysplasia (LMNA)
  • Allelic: Nemaline myopathy 4, AD (TPM2)
  • Allelic: Orofacial cleft 6 (IRF6)
  • Allelic: Polyglucosan body disease, adult form (GBE1)
  • Allelic: Premature ovarian failure 11 (ERCC6)
  • Allelic: Spinocerebellar ataxia, AR 8 (SYNE1)
  • Allelic: Thyrotoxic periodic paralysis, susceptibility to, 1 (CACNA1S)
  • Allelic: Trichothiodystrophy 1, photosensitive (ERCC2)
  • Allelic: UV-sensitive syndrome 1 (ERCC6)
  • Allelic: Xeroderma pigmentosum, group D (ERCC2)
  • Allelic: van der Woude syndrome (IRF6)
  • Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (FGFR2)
  • Arthrogryposis [panelapp] (UTRN)
  • Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect (LGI4)
  • Arthrogryposis multiplex congenita 2, neurogenic type (ERGIC1)
  • Arthrogryposis multiplex congenita 6 (NEB)
  • Arthrogryposis multiplex congenita [panelapp] (UNC50)
  • Arthrogryposis multiplex congenita-pulmonary hypoplasia syndrome
  • Arthrogryposis, distal, type 1A (TPM2)
  • Arthrogryposis, distal, type 1B (MYBPC1)
  • Arthrogryposis, distal, type 2A [Freeman-Sheldon] (MYH3)
  • Arthrogryposis, distal, type 2B1 (TNNI2)
  • Arthrogryposis, distal, type 2B2 (TNNT3)
  • Arthrogryposis, distal, type 2B3 [Sheldon-Hall] (MYH3)
  • Arthrogryposis, distal, type 2B4 (TPM2)
  • Arthrogryposis, distal, type 3 (PIEZO2)
  • Arthrogryposis, distal, type 5 (PIEZO2)
  • Arthrogryposis, distal, type 5D (ECEL1)
  • Arthrogryposis, distal, with impaired proprioception + touch (PIEZO2)
  • Arthrogryposis, renal dysfunction, and cholestasis 1 (VPS33B)
  • Arthrogryposis, renal dysfunction, cholestasis 2 (VIPAS39)
  • Cardiomyopathy, dilated, 1A (LMNA)
  • Carney complex variant (MYH8)
  • Central core disease (RYR1)
  • Centronuclear myopathy 1 (DNM2)
  • Centronuclear myopathy 2 (BIN1)
  • Cerebro-oculo-facio-skeletal (COFS) syndrome (ERCC6)
  • Cerebrooculofacioskeletal syndrome 1 (ERCC6)
  • Cerebrooculofacioskeletal syndrome 2 (ERCC2)
  • Cerebrooculofacioskeletal syndrome 4 (ERCC1)
  • Charcot-Marie-Tooth disease, DI B (DNM2)
  • Charcot-Marie-Tooth disease, axonal type 2M (DNM2)
  • Charcot-Marie-Tooth disease, type 2B1 (LMNA)
  • Congenital arthrogryposis with anterior horn cell disease (GLE1)
  • Congenital disorder of glycosylation, type Ij (DPAGT1)
  • Contractures, pterygia + spondylocarpotarsal fusion syndrome 1A (MYH3)
  • Contractures, pterygia + spondylocarpotarsal fusion syndrome 1B (MYH3)
  • Cortical dysplasia, complex, with other brain malformations 7 (TUBB2B)
  • Emery-Dreifuss muscular dystrophy 2, AD (LMNA)
  • Emery-Dreifuss muscular dystrophy 3, AR (LMNA)
  • Escobar syndrome (CHRNG)
  • Fetal akinesia deformation sequence 1 (MUSK)
  • Fetal akinesia deformation sequence 2 (RAPSN)
  • Fetal akinesia deformation sequence 3 (DOK7)
  • Fetal akinesia, growth restriction [panelapp] (CLTC)
  • Glycogen storage disease IV (GBE1)
  • Hyperkalemic periodic paralysis, type 2 (SCN4A)
  • Hypokalemic periodic paralysis, type 1 (CACNA1S)
  • Hypokalemic periodic paralysis, type 2 (SCN4A)
  • Hypomyelinating neuropathy, congenital, 3 (CNTNAP1)
  • King-Denborough syndrome (RYR1)
  • Lethal congenital contracture syndrome 1 (GLE1)
  • Lethal congenital contracture syndrome 2 (ERBB3)
  • Lethal congenital contracture syndrome 3 (PIP5K1C)
  • Lethal congenital contracture syndrome 4 (MYBPC1)
  • Lethal congenital contracture syndrome 5 (DNM2)
  • Lethal congenital contracture syndrome 6 (ZBTB42)
  • Lethal congenital contracture syndrome 7 (CNTNAP1)
  • Lethal congenital contracture syndrome 8 (ADCY6)
  • Lethal congenital contracture syndrome 9 (ADGRG6)
  • Marden-Walker syndrome (PIEZO2)
  • Minicore myopathy with external ophthalmoplegia (RYR1)
  • Multiple pterygium syndrome, lethal type (CHRNA1, CHRND)
  • Multiple pterygium syndrome, lethal type (CHRNG)
  • Muscular dystrophy, congenital (LMNA)
  • Muscular dystrophy, congenital, Davignon-Chauveau type (TRIP4)
  • Muscular dystrophy, limb-girdle, AR (TTN)
  • Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy (cong. with/-out mental retardation), type B, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy (cong. without mental retardation), type B, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5 (FKRP)
  • Myasthenic syndrome, congenital, 10 (DOK7)
  • Myasthenic syndrome, congenital, 11, ass. w. acetylcholine receptor deficiency (RAPSN)
  • Myasthenic syndrome, congenital, 13, with tubular aggregates (DPAGT1)
  • Myasthenic syndrome, congenital, 16 (SCN4A)
  • Myasthenic syndrome, congenital, 1A, slow-channel (CHRNA1)
  • Myasthenic syndrome, congenital, 1B, fast-channel (CHRNA1)
  • Myasthenic syndrome, congenital, 21, presynaptic (SLC18A3)
  • Myasthenic syndrome, congenital, 3A, slow-channel (CHRND)
  • Myasthenic syndrome, congenital, 3B, fast-channel (CHRND)
  • Myasthenic syndrome, congenital, 3C, ass. w. acetylcholine receptor deficiency (CHRND)
  • Myasthenic syndrome, congenital, 9, ass. w. acetylcholine receptor deficiency (MUSK)
  • Myopathy, XL, with excessive autophagy (VMA21)
  • Myopathy, actin, congenital, with cores (ACTA1)
  • Myopathy, actin, congenital, with excess of thin myofilaments (ACTA1)
  • Myopathy, centronuclear, XL (MTM1)
  • Myopathy, cong., diaphragmatic defects, respiratory insufficiency, dysmorphic face (MYOD1)
  • Myopathy, congenital, Compton-North (CNTN1)
  • Myopathy, congenital, with fiber-type disproportion 1 (ACTA1)
  • Myopathy, congenital, with tremor (MYBPC1)
  • Myopathy, myofibrillar, 9, with early respiratory failure (TTN)
  • Myopathy, scapulohumeroperoneal (ACTA1)
  • Myotonia congenita, atypical, acetazolamide-responsive (SCN4A)
  • Myotonic dystrophy 1 (DMPK_CTG)
  • Nemaline myopathy 10 (LMOD3)
  • Nemaline myopathy 2, AR (NEB)
  • Nemaline myopathy 3, AD/AR (ACTA1)
  • Nemaline myopathy 8, AR (KLHL40)
  • Nemaline myopathy 9 (KLHL41)
  • Neuromuscular disease, congenital, with uniform type 1 fiber (RYR1)
  • Paramyotonia congenita (SCN4A)
  • Pena Shokeir I/II syndromes
  • Popliteal pterygium syndrome 1 (IRF6)
  • Popliteal pterygium syndrome, Bartsocas-Papas type (RIPK4)
  • Restrictive dermopathy 2 (LMNA)
  • Salih myopathy (TTN)
  • Schaaf-Yang syndrome (MAGEL2)
  • Spinal muscular atrophy with congenital bone fractures 1 (TRIP4)
  • Spinal muscular atrophy with congenital bone fractures 2 (ASCC1)
  • Spinal muscular atrophy, XL 2, infantile (UBA1)
  • Spinal muscular atrophy, lower extremity-predominant, 2A + 2B, AD (BICD2)
  • Spinal muscular atrophy-1, -2, -3, -4 (SMN1)
  • Tibial muscular dystrophy, tardive (TTN)
  • Trismus-pseudocamptodactyly syndrome (MYH8)
  • Visceral neuropathy, familial, 1, AR (ERBB3)
  • Wieacker-Wolff syndrome (ZC4H2)
  • Wieacker-Wolff syndrome, female-restricted (ZC4H2)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XLR
  • n.k.
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code
Q87.8

Bioinformatics and clinical interpretation

No text defined